Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells

✍ Scribed by Martin S. Spitzer; Efdal Yoeruek; Ana Sierra; Barbara Wallenfels-Thilo; Ulrich Schraermeyer; Bernhard Spitzer; Karl U. Bartz-Schmidt; Peter Szurman

• Book ID: 106097675
• Publisher: Springer-Verlag
• Year: 2007
• Tongue: English
• Weight: 262 KB
• Volume: 245
• Category: Article
• ISSN: 0065-6100
• DOI: 10.1007/s00417-007-0568-7